← Open Payments lookup

MICHAEL SCHWARTZ: Open Payments

NPI 1861584708 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$966 in 47 payments from 8 companies in 2025. Trend: 2023 $206 · 2024 $751 · 2025 $966

Food & beverage: $966
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$255
Alkermes, Inc.9$236
Otsuka America Pharmaceutical, Inc.8$174
Teva Pharmaceuticals USA, Inc.6$112
E.R. Squibb & Sons, L.L.C.3$84
Luye Pharma (USA) Ltd.3$56
Vanda Pharmaceuticals Inc.1$26
Janssen Pharmaceuticals, Inc1$23

Products named: INGREZZA, ARISTADA, ABILIFY MAINTENA, AUSTEDO XR, COBENFY, ERZOFRI EXTENDED-RELEASE, FANAPT, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.